BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP
42 results:

  • 1. Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study.
    Lippert J; Dischinger U; Appenzeller S; Prete A; Kircher S; Skordilis K; Elhassan YS; Altieri B; Fassnacht M; Ronchi CL
    Eur J Endocrinol; 2023 Aug; 189(2):262-270. PubMed ID: 37590967
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A Rare Case of Ovarian Double-Hit/Diffuse Large B-Cell Lymphoma: A Case Report and Review of Literature.
    Urella M; Nwanwene K; Sidda A; Pacioles T
    J Investig Med High Impact Case Rep; 2023; 11():23247096231154641. PubMed ID: 36840472
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast cancer and High-grade Serous Ovarian cancer.
    Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
    JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma.
    Lippert J; Altieri B; Morrison B; Steinhauer S; Smith G; Lorey A; Urlaub H; Kircher S; Sitch A; Fassnacht M; Ronchi CL
    J Clin Endocrinol Metab; 2022 Sep; 107(10):2892-2899. PubMed ID: 35929659
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Healthy lifestyle index and risk of pancreatic cancer in the Women's Health Initiative.
    Peila R; Coday M; Crane TE; Saquib N; Shadyab AH; Tabung FK; Zhang X; Wactawski-Wende J; Rohan TE
    Cancer Causes Control; 2022 May; 33(5):737-747. PubMed ID: 35235084
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy.
    Sunagawa Y; Hayashi M; Yamada S; Tanabe H; Kurimoto K; Tanaka N; Sonohara F; Inokawa Y; Takami H; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Clin Epigenetics; 2021 Sep; 13(1):172. PubMed ID: 34530906
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dietary Patterns of Insulinemia, Inflammation and Glycemia, and Pancreatic cancer Risk: Findings from the Women's Health Initiative.
    Jin Q; Hart PA; Shi N; Joseph JJ; Donneyong M; Conwell DL; Clinton SK; Cruz-Monserrate Z; Brasky TM; Tinker LF; Liu S; Shadyab AH; Thomson CA; Qi L; Rohan T; Tabung FK
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1229-1240. PubMed ID: 33827986
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. DGCR5 is activated by pax5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway.
    Liu SL; Cai C; Yang ZY; Wu ZY; Wu XS; Wang XF; Dong P; Gong W
    Int J Biol Sci; 2021; 17(2):498-513. PubMed ID: 33613108
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sleep Characteristics and Risk of Ovarian cancer Among Postmenopausal Women.
    Liang X; Harris HR; Hendryx M; Shadyab AH; Hale L; Li Y; Crane TE; Cespedes Feliciano EM; Stefanick ML; Luo J
    Cancer Prev Res (Phila); 2021 Jan; 14(1):55-64. PubMed ID: 32917642
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Upregulation of CD20 Positive B-Cells and B-Cell Aggregates in the Tumor Infiltration Zone is Associated with Better Survival of Patients with Pancreatic Ductal Adenocarcinoma.
    Brunner M; Maier K; Rümmele P; Jacobsen A; Merkel S; Benard A; Krautz C; Kersting S; Grützmann R; Weber GF
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150869
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer.
    Timmermans M; Zwakman N; Sonke GS; Van de Vijver KK; Duk MJ; van der Aa MA; Kruitwagen RF
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():364-369. PubMed ID: 31400565
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clonal evolution of chronic lymphocytic leukemia to Langerhans cell histiocytosis: a case report.
    Frauenfeld L; Bonzheim I; Wirths S; Steinhilber J; Horger M; Mankel B; Bethge W; Fend F; Federmann B
    Virchows Arch; 2019 Dec; 475(6):795-798. PubMed ID: 31317311
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Double-hit pancreatic B-lymphoblastic lymphoma with a variant translocation t(2;18)(p11;q21).
    Yamamoto K; Kawamoto S; Kitao A; Mizutani Y; Inui Y; Yakushijin K; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
    Int J Hematol; 2019 Jul; 110(1):107-114. PubMed ID: 30963474
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Intravascular Large B-Cell Lymphoma Within a Thyroid Nodule: A Diagnostic Pitfall.
    Linnik Y; Nicka C; Lansigan F; Loo E; Liu X
    Int J Surg Pathol; 2018 Aug; 26(5):428-431. PubMed ID: 29569516
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tibolone and risk of gynecological hormone sensitive cancer.
    Løkkegaard ECL; Mørch LS
    Int J Cancer; 2018 Jun; 142(12):2435-2440. PubMed ID: 29349823
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant expression of CD20 in thyroid cancer and its clinicopathologic significance.
    Bychkov A; Jung CK
    Hum Pathol; 2018 Jan; 71():74-83. PubMed ID: 29079175
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Benign breast disease and risk of thyroid cancer.
    Luo J; Hendryx M; Nassir R; Cheng TD; Lane D; Margolis KL
    Cancer Causes Control; 2017 Sep; 28(9):913-920. PubMed ID: 28681104
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Clinicopathologic features and expression of OCT4 protein in testicular diffuse large B cell lymphoma].
    Chen YP; Zhu WF; Chen LF; Lu JP; He TM; Fu WD; Xu CW; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):383-387. PubMed ID: 28591984
    [No Abstract]    [Full Text] [Related]  

  • 19. A Rare Case of CK20/CK7 Double Negative Merkel Cell Carcinoma.
    Le MD; OʼSteen LH; Cassarino DS
    Am J Dermatopathol; 2017 Mar; 39(3):208-211. PubMed ID: 28221211
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical cancer.
    Jouinot A; Assie G; Libe R; Fassnacht M; Papathomas T; Barreau O; de la Villeon B; Faillot S; Hamzaoui N; Neou M; Perlemoine K; Rene-Corail F; Rodriguez S; Sibony M; Tissier F; Dousset B; Sbiera S; Ronchi C; Kroiss M; Korpershoek E; de Krijger R; Waldmann J; K D; Bartsch ; Quinkler M; Haissaguerre M; Tabarin A; Chabre O; Sturm N; Luconi M; Mantero F; Mannelli M; Cohen R; Kerlan V; Touraine P; Barrande G; Groussin L; Bertagna X; Baudin E; Amar L; Beuschlein F; Clauser E; Coste J; Bertherat J
    J Clin Endocrinol Metab; 2017 Mar; 102(3):923-932. PubMed ID: 27967600
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.